Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?

Literature DB >> 17342388

CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?

Salvatore Madonia¹, Emma Aragona, Simonetta Maisano, Luigi Montalbano, Mirko Olivo, Francesca Rossi, Gaetano Restivo, Mario Cottone.

Abstract

Entities: Disease Species

Mesh：

Substances：
CA-19-9 Antigen

Year: 2007 PMID： 17342388 DOI： 10.1007/s10620-006-9532-3

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

14 in total

1. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors: A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal: Am J Gastroenterol Date: 2000-01 Impact factor: 10.864

Review 2. Elevated CA 19-9 caused by Hashimoto's thyroiditis: review of the benign causes of increased CA 19-9 level.

Authors: Javier L Parra; Steven Kaplan; Jamie S Barkin
Journal: Dig Dis Sci Date: 2005-04 Impact factor: 3.199

3. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis.

Authors: Kazumi Suzuki; Osamu Muraishi; Akihiko Tokue
Journal: J Urol Date: 2002-01 Impact factor: 7.450

4. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

Authors: R C Bast; P Ravdin; D F Hayes; S Bates; H Fritsche; J M Jessup; N Kemeny; G Y Locker; R G Mennel; M R Somerfield
Journal: J Clin Oncol Date: 2001-03-15 Impact factor: 44.544

5. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

Authors: H J Kim; M H Kim; S J Myung; B C Lim; E T Park; K S Yoo; D W Seo; S K Lee; Y I Min
Journal: Am J Gastroenterol Date: 1999-07 Impact factor: 10.864

1. Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.

Authors: S L Ong; A Sachdeva; G Garcea; G Gravante; M S Metcalfe; D M Lloyd; D P Berry; A R Dennison
Journal: Dig Dis Sci Date: 2008-05-09 Impact factor: 3.199

1 in total

CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?

1. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Review 2. Elevated CA 19-9 caused by Hashimoto's thyroiditis: review of the benign causes of increased CA 19-9 level.

3. The correlation of serum carbohydrate antigen 19-9 with benign hydronephrosis.

4. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology.

5. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.

6. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.

7. High CA 19-9 levels in benign biliary tract diseases. Report of four cases and review of the literature.

8. Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus.

9. Elevated serum levels of tumor marker CA19-9 in acute cholangitis.

Review 10. Extraordinarily elevated CA19-9 in benign conditions: a case report and review of the literature.

1. Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.